Now scientists are conducting more than 20 studies of hydroxychloroquine as a therapy against COVID-19, in particular, researchers from the USA, Great Britain, Spain, China and other countries. Antimalarial drugs for the treatment of patients with COVID-19 are permitted in a number of countries, but with certain restrictions. A new American study indicates the inefficiency of hydroxychloroquine, as an independent treatment or in combination with other drugs against COVID-19, writes BBC.
See also: Overcome coronavirus without vaccine: China announced "revolutionary" drugs
Scientists have declared the dangers of treatment with COVID-19 popular drugs
According to new recommendations, hydroxychloroquine and chloroquine cannot be used in the treatment of COVID-19.
So far, the prescription of drugs has been justified only within the framework of clinical trials, and after studying the patient’s medical history and well-being, doctors have discovered a significant number of side effects.
According to scientists, among the most common side effects: cardiovascular disorders, complications in the eyes, kidneys and liver, anemia, rash and others.
Therefore, researchers at Oxford University noted that while data on the effectiveness of antimalarial drugs is too small to continue to be used in the treatment of patients with coronavirus disease.
Plaquenil is ineffective against coronavirus / Photo Unsplash
Although the FDA has authorized the emergency use of these drugs to treat COVID-19 for a limited number of patients. Other countries, on their own, also decided to use them for treatment in a pandemic.
You need to know: What medicines are offered to treat coronavirus: a list
What are antimalarial drugs
Hydroxychloroquine and chloroquine – these drugs are supplied under the name Plaquenil. Chloroquine is used to treat malaria, and hydroxychloroquine is used to treat rheumatoid arthritis or systemic lupus erythematosus.
Important! According to the CDC, there are no data on the results of clinical trials of hydroxychloroquine for the treatment of COVID-19 to be included in clinical guidelines.
Plaquenil – antimalarial drugs Plaquenil is an antimalarial drug that belongs to the group of immunosuppressants. Its effect is to reduce the activity of the immune system. Plaquenil is usually used to treat arthritis of varying severity, malaria, and skin and lupus diseases.
Plaquenil Treatment in Ukraine
Ukraine in April received a batch of the drug Plaquenil. So, the head of the Ministry of Health Maxim Stepanov said that the drug has an active substance that is effective against coronavirus. Consequently, the Ukrainian Ministry of Health has additionally agreed with a number of pharmaceutical companies to supply drugs containing the same active substance as Plaquenil.
Previously, the price of Plaquenil in Ukraine was about 500 hryvnias per pack, but then it increased significantly.
For more news regarding treatment, medicine, nutrition, a healthy lifestyle, and more, read the Health section.